Courageous. Focused. Passionate.

Pioneering Development of Life-Changing Treatments by Leveraging the Untapped Mechanisms of the Lysosome

Disease for which medicine offers few effective options-advanced cancer, neurodegenerative diseases, lysosomal storage diseases and autoimmune diseases-persist because they involve very complex and interrelated cellular operations. Bexion is committed to unlocking the workings of the lysosome, the key cellular orchestrator, to provide patients effective, non-toxic therapies where none currently exist.

banner-info
Home – New2021-05-12T10:49:29-04:00

– Our Platform

An innovative, targeted approach to treating cancer

Our treatment specifically targets unique features of cancer cells, including externalized phosphatidylserine and tumor cell lysosomes by utilizing a small lysosomal protein known as Saposin C.

Learn More

– Our Pipeline

A Pipeline-in-a-Product asset with potential for multiple indications

BXQ-350 is the foundation of our pipeline. Early clinical results have shown a strong safety and tolerability profile.

Learn More

– clinical trials

Update

Our clinical trials are regulated by the Food and Drug Administration (FDA) in the United States and by similar regulatory agencies worldwide.

Learn More

Resources

Bexion Resources

Resources

Learn More
View All Resources

News

    Press Release

    Bexion Pharmaceuticals, Inc. to Present at the 2021 Association for Cancer Immunotherapy (CIMT) Annual Meeting

    April 20, 2021

    FOR IMMEDIATE RELEASE [Covington, KY---April 20, 2021] Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced today that an abstract submitted for an eTalk Session at the CIMT annual meeting to be held virtually May 10-12, 2021 has been chosen for presentation. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the ... Read More

      Press Release

      New Segment of Advancements to Focus on Breakthroughs in Targeted Cancer Cell Treatment

      April 12, 2021

      Jupiter, FL— The award-winning series, Advancements with Ted Danson, will focus on an innovative, targeted approach to treating a range of diseases during 3Q/2021. Check local listings for more information. The diseases for which medicine offers few effective options – advanced cancer (or even early-stage cancer for certain types), neurodegenerative diseases and autoimmune diseases – persist because ... Read More

      View All Media